Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | CCR2 | P41597 | 4/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | SLC40A1 | Q9NP59 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.36 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29335302 | 0.91 | PTGES2 (0.41) | ACLYCCR2FABP4IDH1SLC40A1 | |
| SCHEMBL29335304 | 0.86 | CCR2 (0.44) | ACLYCCR2SLC40A1ALDH1A1PTGES2 | |
| SCHEMBL29335266 | 0.84 | FABP4 (0.50) | ACLYFABP4ALDH1A1TSHRPOLB | |
| SCHEMBL29335256 | 0.83 | SLC40A1 (0.54) | ACLYCCR2SLC40A1PTGES2TSHR | |
| SCHEMBL29335307 | 0.81 | SLC40A1 (0.43) | SLC40A1PTGES2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL29335255 | 0.80 | SLC40A1 (0.51) | ACLYCCR2SLC40A1PTGES2PIK3CD | |
| SCHEMBL29335270 | 0.79 | ALDH1A1 (0.50) | ACLYFABP4ALDH1A1PTGES2TSHR | |
| SCHEMBL3019464 | 0.78 | CCR2 (0.59) | ACLYCCR2PTGES2TSHRPOLB | |
| SCHEMBL30681726 | 0.78 | VSIR (0.37) | CCR2FABP4IDH1SLC40A1PTGES2 | |
| SCHEMBL27146891 | 0.78 | VSIR (0.37) | CCR2FABP4IDH1SLC40A1PTGES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239801-A1 | PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Université de Montréal (CA) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239801-A1 | PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | NRAS, BRAF, KRAS | ACLY 3912/4885CCR2 1702/4885FABP4 4665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.